NASH Drug Shown to Reduce Liver Fat by 65% in Some Patients NASH Drug Shown to Reduce Liver Fat by 65% in Some Patients
Akero Therapeutics said on Monday data from a mid-stage study showed its experimental therapy reduced liver fat by 65% in certain patients with a type of fatty liver disease called nonalcoholic steatohepatitis.Reuters Health Information
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Gastroenterology News Source Type: news
More News: Fatty Liver Disease (FLD) | Gastroenterology | Liver | Liver Disease | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology